MEDTRONIC MEDTECH INNOVATION ACCELERATOR
SYNERGIZING BUSINESSES AND GOVERNMENT RESOURCES FOR "INNOVATION, SHARING, ACCELERATING"点击提交申请 / CLICK HERE TO APPLY
Medtronic MedTech Innovation Accelerator, located in Shanghai, is a platform for empowering collaborative innovation. As a Medtronic initiative, it will accelerate the conversion of bright ideas into valuable medical products and services, serving the China market with accessible medical solutions to improve patient outcomes. Medtronic MedTech Innovation Accelerator will also contribute to China’s goal to become a science and technology innovation hub with global influence.
As an addition to the Medtronic Greater China network, Medtronic MedTech Innovation Accelerator has received endorsement from Minhang District government of Shanghai and Lingang Economic Development (Group) Co., Ltd. It is located close to the Medtronic China R&D Center in Pujiang International Science and Technology City, Minhang District, Shanghai, and boasts 1,000 square meters during the first phase of its establishment. Its facilities and equipment are made available to 10 Medtronic MedTech Innovation Accelerator portfolio companies for their R&D and administrative work, when these companies are also granted access to strong resources in the Medtronic R&D network.
Medtronic MedTech Innovation Accelerator starts operation officially on March 25, 2019.
Synergizing businesses and government resources for “Innovating, Sharing, Accelerating”
Medtronic MedTech Innovation Accelerator is committed to empowering early-stage MedTech start-ups with strong potential to transform technologies in labs into accessible medical solutions and creating value by serving patient needs and evolving industry capabilities.
Leveraging Expertise in Innovation
Medtronic MedTech Innovation Accelerator takes advantage of the company’s 70-year innovation heritage and assets across more than 70 therapeutic areas and its operation footprint across more than 150 countries and markets, including China. It is dedicated to identifying meaningful medtech innovation and helping it to grow and enable its access to markets and to patients.
Featuring Emerging Innovation
Medtronic MedTech Innovation Accelerator will be focused on a wide range of emerging medtech that can improve lives, such as artificial intelligence, surgical robotics, bioengineering, and new materials. It will prioritize support for medical applications that present prospective ground-breaking or disruptive innovations across the world, as well as capabilities in narrowing the gap for serving Chinese patients.
Medtronic MedTech Innovation Accelerator portfolio companies are granted a workplace for coworking and R&D, access to advanced lab equipment at the Medtronic Technology Center, and advice from Medtronic China R&D staff. On top of the support in early-stage innovation, other potential Medtronic support for promising programs includes guidance on clinical research, product registration, outsourced manufacturing solutions, and professional clinical education of physician customers at the company’s clinical training centers in China.
Pujiang International Science and Technology City, owned by Shanghai Lingang Economic Development (Group) Co., Ltd., boasts a strong network and deep understanding of policies. It provides Medtronic MedTech Innovation Accelerator portfolio companies with added value through services ranging from human resources, finance, intellectual property, legal, government project declaration, investment and funding to equity financing, listing financial advisory, and science & technology project applications.
Through its partnerships that are set to unleash further medtech potential, Medtronic MedTech Innovation Accelerator is expected to improve patient outcomes and the healthcare system’s economic value, as well as contribute to China’s goal of becoming a science and technology innovation hub with global influence.
Empower early-stage MedTech start-ups, with real potential in clinical outcomes and market performance, accelerating the process from an idea in a lab, to an accessible therapy in the market.
Tapping into Medtronic’s rich experience in product registration and market access, realize localization and application in a shorter time, so that patients can benefit from more efficient medical solutions while enabling a thriving environment for innovation.
Evolving innovation strategy with enforced collaborative platform covering the full lifecycle of innovation
The addition of Medtronic MedTech Innovation Accelerator to the company’s collaborative innovation network enables more capabilities for medtech start-ups in different business stages, supporting their innovation from the ideation stage through to marketable products.
Medtronic MedTech Innovation Accelerator
Mainly supports early-stage start-ups to optimize their products and prepare for clinical trials.
Medtronic China Venture Fund
Mainly provides support in funding and marketing strategy for partnering businesses with products to be marketed.
Medtronic Business Development Function
Mainly partners with businesses with marketed products to expand their market access through acquisitions or dealer agreements.